Moderna's mRNA Flu Vaccine Receives FDA Approval

The U.S. Food and Drug Administration has approved Moderna's mRNA-based influenza vaccine, marking a significant development in flu prevention. This regulatory action introduces a novel type of flu shot to the market, offering a new option for public health. The approval could influence future vaccine development and public health strategies.